<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Oral Dosage Form New Animal Drugs; Phenylpropanolamine</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Oral Dosage Form New Animal Drugs; Phenylpropanolamine</h1>
    <p class="timestamp">Published: 2012-03-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Pegasus Laboratories, Inc. The NADA provides for the veterinary prescription use of phenylpropanolamine hydrochloride chewable tablets for the control of urinary incontinence due to urethral sphincter hypotonus in dogs.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-6553</p>
    <p><strong>Publication Date:</strong> 2012-03-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/03/19/2012-6553/oral-dosage-form-new-animal-drugs-phenylpropanolamine">https://www.federalregister.gov/documents/2012/03/19/2012-6553/oral-dosage-form-new-animal-drugs-phenylpropanolamine</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-6553</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
